Search

everythinglearnresearchcommunity

for

Search:↓

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Bariatric surgery improves ovulation rates in women with PCOS and obesity better than medical therapy.

Men with high genetic risk for Polycystic Ovary Syndrome (PCOS) have increased chances of obesity, type 2 diabetes, heart disease, and hair loss, showing PCOS risk factors can affect both genders.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.

Women with Polycystic Ovary Syndrome (PCOS) have a lower health-related quality of life, especially those with an anovulatory phenotype, and need specific interventions to improve it.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

About 3% of high school girls aged 14-18 in Isfahan, Iran, have polycystic ovary syndrome.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Acne is an important sign of androgen excess disorders in women.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

PCOS is a common hormonal disorder in women that can affect skin, fertility, and metabolism, and treatment is tailored to individual needs.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.